Advisors lead their fields in patent law, nutraceuticals & ethnobotany VANCOUVER, BC, Feb. 1, 2022 – Numinus’s Wellness Inc. (TSX:NUMI)(OTCPK:LKYSF)(“Numinus” or the “Company”), a mental healthcare company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, is pleased to announce…
Helping you earn through partnerships.
Our top priority is to help you learn and earn. Our articles are provided free of charge, and
the information found here can help you build wealth for life. We offer an independent
perspective on financial services, financial markets, and good practices for personal
finance. Our main goal is to help you grow your money.
Wealthy Millionaire helps you earn by recommending services through our carefully vetted list of partnerships. Our research and professional insight were built through years of financial industry experience, and our recommended products are based on an independent analysis of the best service providers in the market. These recommendations are objective; we do not accept special payments to recommend products and services from our partners.
Loan offers that appear on this site are from companies from which Wealthy Millionaire receives compensation. This compensation may impact how and where products appear on this site (including, for example, the order in which they appear). Wealthy Millionaire does not include all lenders or loan offers available in the marketplace.
VANCOUVER, BC, Oct. 20, 2021 /CNW/ – Numinus Wellness Inc. (TSXV:NUMI)(OTCPK:LKYSF) (“Numinus” or the “Company”), a leader in psychedelics-focused mental healthcare, is pleased to have finalized the study design and protocol for a Phase 1 clinical trial on…